You are here

lenzilumab

Humanigen says its antibody reduced need for ventilation in COVID-19 patients by 54%

Humanigen says its antibody reduced need for ventilation in COVID-19 patients by 54%

Beckers Hospital Review

Flag link:

Humanigen announces first patient dosed in phase 3 clinical study of lenzilumab in Covid-19

Humanigen announces first patient dosed in phase 3 clinical study of lenzilumab in Covid-19

Pharmaceutical Business Review

clinical trials

Flag link:

A drug from Shkreli's former company Humanigen shows early promise in COVID-19

A drug from Shkreli's former company Humanigen shows early promise in COVID-19

Fierce Biotech

Flag link: